首页> 外文期刊>Radiation oncology >Spinal bone metastases in colorectal cancer: a retrospective analysis of stability, prognostic factors and survival after palliative radiotherapy
【24h】

Spinal bone metastases in colorectal cancer: a retrospective analysis of stability, prognostic factors and survival after palliative radiotherapy

机译:大肠癌脊柱骨转移:姑息性放疗后的稳定性,预后因素和生存率的回顾性分析

获取原文
           

摘要

Background This retrospective analysis aimed to analyse the stability of spinal bone metastases in colorectal cancer (CRC) patients following radiotherapy (RT) by use of a validated score and to assess prognostic factors for stability and survival. Methods Ninety-four patients with osteolytic spinal bone metastases from CRC were treated at the Department of Radiation Oncology at the University Hospital Heidelberg between 2000 and 2014. The stability of each affected vertebral body was assessed according to the validated Taneichi bone stability score on the basis of the treatment planning CT scan prior to RT and also based on the follow-up CT examinations at 3 and 6?months after RT. Additionally, bone survival rates (time between first day of RT and death from any cause) as well as prognostic factors for bone survival were evaluated for all study patients. Results Before RT, 59 patients (63%) were rated unstable according to the Taneichi score. Pathological fractures within the irradiated region were diagnosed in 43 patients (46%) prior to RT. New fractures or progression of previously collapsed vertebrae were diagnosed in 4 patients (4%) after irradiation. Significant re-calcification and stabilization of former unstable bone metastases was only observed in 3/59 patients (3%) and 5/59 patients (9%). The median bone survival was 4.2?months (range 0.5–67.3?months) and 6?months after RT 61% of the patients were dead. Karnofsky performance score (KPS) ( Conclusions Our study population is characterized by poor bone survival and low re-calcification rates of unstable spinal bone lesions 3 and 6?months after RT. To avoid unnecessary hospitalisation and improve remaining QoL, short fractionated treatment schedules of RT may be prefered in this highly palliative situation, particularly for patients with a KPS
机译:背景这项回顾性分析旨在通过使用经过验证的评分来分析放射治疗(RT)后结直肠癌(CRC)患者的脊柱骨转移瘤的稳定性,并评估其稳定性和生存期的预后因素。方法2000年至2014年间,在海德堡大学医院放射肿瘤科对94例CRC引起的溶骨性脊柱骨转移的患者进行了治疗。在此基础上,通过验证的Taneichi骨稳定性评分评估每个患椎体的稳定性计划在放疗前进行CT扫描以及在放疗后3个月和6个月进行的后续CT检查。此外,评估了所有研究患者的骨存活率(RT第一天到因任何原因死亡之间的时间)以及骨存活的预后因素。结果RT之前,根据Taneichi评分将59例患者(63%)评为不稳定。在放疗前,有43例(46%)患者被诊断出受照射区域内的病理性骨折。放射后4例(4%)被诊断出新的骨折或先前塌陷的椎骨进展。仅在3/59例患者(3%)和5/59例患者(9%)中观察到前不稳定骨转移的明显重新钙化和稳定。在RT后61%的患者死亡的中位骨存活时间为4.2个月(0.5-67.3个月)和6个月。 Karnofsky绩效评分(KPS)(结论我们的研究人群的特点是在RT后3和6个月,骨存活率差,不稳定脊柱骨病变的再钙化率低。为避免不必要的住院治疗和改善剩余QoL,短期分期治疗在这种高度姑息的情况下,RT可能更可取,尤其是对于KPS患者

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号